Platelet function studies in myeloproliferative neoplasms patients with Calreticulin or JAK2V617F mutation

Abstract excerpt

Background: -mutated blood platelets would have platelet function defects that might explain why these patients are at lower risk of thrombosis. Objectives: Our main objective was to explore and compare platelet function depending on the MPN molecular marker. Methods: mutation and compared them with healthy controls. None of these patients was taking antiplatelet therapy. We performed an extensive analysis of...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Chronic Myeloid Leukemia Treatments
• Share to Kruppel-like factors research
• Share to Myeloproliferative Neoplasms: Diagnosis and Treatment